المؤلفون: Vizcaíno y de Sas, Eduardo.

مصطلحات موضوعية: Authors, Spanish -- 20th century -- Biography., Vizcaíno Casas, Fernando, 1926- Biografía.

Subject Person: Vizcaíno Casas, Fernando -- Biography.

المؤلفون: Jimenez, MM, Zielinski, C, Ruiz-Borrego, M, Carrasco, E, Ciruelos, EM, Munoz, M, Bermejo, B, Margeli, M, Csoszi, T, Anton, A, Turner, N, Casas, MI, Morales, S, Alba, E, Calvo, L, De la Haba, J, Ramos, M, Corsaro, M, Kahan, Z, Gil-Gil, M

المصدر: Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::0fee28c3aef451538129fd7d7918a35a
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1852

المؤلفون: Martín M; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. Electronic address: mmartin@geicam.org., Zielinski C; Vienna Cancer Center, Medical University Vienna and Vienna Hospital Association, Vienna, Austria; CECOG, Central European Cooperative Oncology Group, Vienna, Austria., Ruiz-Borrego M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Universitario Virgen Del Rocío, Sevilla, Spain., Carrasco E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Ciruelos EM; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; HM Hospitales Madrid, Spain; SOLTI Group on Breast Cancer Research., Muñoz M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Translational Genomics and Targeted Therapies in Solid Tumours, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain., Bermejo B; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain; Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria-INCLIVA Valencia, Spain., Margelí M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Badalona Applied Research Group in Oncology (ARGO Group), Institut Catalá D'Oncologia, Hospital Universitari Germans Trias I Pujol, Badalona, Spain., Csöszi T; CECOG, Central European Cooperative Oncology Group, Vienna, Austria; Department of Oncology, Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelőintezet, Szolnok, Hungary., Antón A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón-IISA, Zaragoza, Spain., Turner N; Institute of Cancer Research and Royal Marsden, London, UK., Casas MI; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Morales S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology. Hospital Universitario Arnau de Vilanova, Lleida, Spain., Alba E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain; UGCI Medical Oncology, Hospitales Regional y Virgen de La Victoria. IBIMA. Málaga, Spain., Calvo L; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., de la Haba-Rodríguez J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain; Instituto Maimonides de Investigación Biomédica, Hospital Reina Sofía Hospital, Universidad de Córdoba, Córdoba, Spain., Ramos M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Centro Oncológico de Galicia, A Coruña, Spain., Murillo L; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Clínico de Zaragoza Lozano Blesa, Zaragoza, Spain., Santaballa A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Alonso-Romero JL; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Universitario Virgen de La Arrixaca-IMIB, Murcia, Spain., Sánchez-Rovira P; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Oncology Unit, Universitary Hospital Jaén, Spain., Corsaro M; Pfizer Inc., Milan, Italy., Huang X; Pfizer Inc., San Diego, USA., Thallinger C; CECOG, Central European Cooperative Oncology Group, Vienna, Austria; Department of Oncology, Medical University of Vienna, Austria., Kahan Z; CECOG, Central European Cooperative Oncology Group, Vienna, Austria; Department of Oncotherapy, University of Szeged, Szeged, Hungary., Gil-Gil M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Institut Català D'Oncologia (ICO) & IDIBELL, L'Hospitalet, Barcelona, Spain.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jun; Vol. 168, pp. 12-24. Date of Electronic Publication: 2022 Apr 13.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology, Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Aromatase Inhibitors/therapeutic use ; Capecitabine/therapeutic use ; Female ; Fulvestrant/therapeutic use ; Humans ; Piperazines ; Postmenopause ; Pyridines ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism

المؤلفون: Villodre C; Hospital Gran Canaria Doctor Negrín, Las Palmas de Gran Canarias, Spain Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain Hospital Lluís Alcanyís de Xàtiva, Valencia, Spain Hospital Universitario de Badajoz, Badajoz, Spain Hospital Universitario de Bellvitge, Barcelona, Spain Hospital Marina Baixa, Alicante, Spain Hospital Juan Ramón Jiménez, Infanta Elena, Huelva, Spain Hospital Infanta Cristina, Parla, Madrid, Spain Hospital Universitario de Canarias, Tenerife, Spain Hospital Reina Sofía de Córdoba, Córdoba, Spain H. Ramón y Cajal, Madrid, Spain Hospital Parc Taulí de Sabadell, Barcelona, Spain Hospital General Universitario de Alicante, Alicante, Spain Complejo Hospitalario Universitario de Vigo, Hospital Pontevedra, Spain Hospital Trueta de Girona, Girona, Spain Hospital Universitario Rio Hortega, Valladolid, Spain Hospital Mutua Terrassa, Barcelona, Spain Consorci Hospitalari de Vic, Barcelona, Spain POVISA, Pontevedra, Spain Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain Hospital Universitario Basurto, Bizkaia, Spain Hospital Universitario Marqués de Valdecilla, Santander, Spain Hospital de Viladecans, Barcelona, Spain Hospital Clínico de Valencia, Valencia, Spain Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain Hospital Vírgen de la Macarena, Sevilla, Spain Hospital Cabueñes, Gijón, Spain Complejo Hospitalario de Jaén, Jaén, Spain Hospital Universitari Sant Joan de Reus, Tarragona, Spain Hospital Universitario Infanta Sofía, Madrid, Spain Complejo Hospitalario Torrecárdenas, Almería, Spain Hospital Sant Pau i Santa Tecla, Tarragona, Spain Hospital General Rafael Méndez de Lorca, Murcia, Spain Hospital Vírgen del Rocío, Sevilla, Spain Hospital Morales Meseguer, Murcia, Spain Hospital del Vinalopó, Alicante, Spain Hospital Universitario del Vinalopó, Alicante, Spain Hospital Universitario Virgen de las Nieves, Granada, Spain Department of Surgery, General University Hospital of Alicante, Alicante, Spain Department of Clinical Pharmacology, General University Hospital of Alicante, Alicante, Spain Computing, BomhardIP, Alicante, Spain Department of Clinical Documentation, General University Hospital of Alicante, Alicante, Spain Institute of Health and Biomedical Research of Alicante, ISABIAL, Alicante, Spain., Taccogna L, Zapater P, Cantó M, Mena L, Ramia JM, Lluís F, Afonso N, Aguilella V, Aguiló J, Alados JC, Alberich M, Apio AB, Balongo R, Bra E, Bravo-Gutiérrez A, Briceño FJ, Cabañas J, Cánovas G, Caravaca I, Carbonell S, Carrera-Dacosta E, Castro EE, Caula C, Choolani-Bhojwani E, Codina A, Corral S, Cuenca C, Curbelo-Peña Y, Delgado-Morales MM, Delgado-Plasencia L, Doménech E, Estévez AM, Feria AM, Gascón-Domínguez MA, Gianchandani R, González C, Hevia RJ, González MA, Hidalgo JM, Lainez M, Lluís N, López F, López-Fernández J, López-Ruíz JA, Lora-Cumplido P, Madrazo Z, Marchena J, de la Cuadra MB, Martín S, Casas MI, Martínez P, Mena-Mateos A, Morales-García D, Mulas C, Muñoz-Forner E, Naranjo A, Navarro-Sánchez A, Oliver I, Ortega I, Ortega-Higueruelo R, Ortega-Ruiz S, Osorio J, Padín MH, Pamies JJ, Paredes M, Pareja-Ciuró F, Parra J, Pérez-Guarinós CV, Pérez-Saborido B, Pintor-Tortolero J, Plua-Muñiz K, Rey M, Rodríguez I, Ruiz C, Ruíz R, Ruiz S, Sánchez A, Sánchez D, Sánchez R, Sánchez-Cabezudo F, Sánchez-Santos R, Santos J, Serrano-Paz MP, Soria-Aledo V, Tallón-Aguilar L, Valdivia-Risco JH, Vallverdú-Cartié H, Varela C, Villar-Del-Moral J, Zambudio N

مؤلفون مشاركون: LUCENTUM Project Researchers

المصدر: International journal of surgery (London, England) [Int J Surg] 2022 Jan; Vol. 97, pp. 106168. Date of Electronic Publication: 2021 Nov 14.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101228232 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-9159 (Electronic) Linking ISSN: 17439159 NLM ISO Abbreviation: Int J Surg Subsets: MEDLINE

مواضيع طبية MeSH: General Surgery* , Surgical Procedures, Operative*, Adult ; Aged ; Benchmarking ; Cohort Studies ; Emergencies ; Female ; Hospital Mortality ; Humans ; Middle Aged ; Postoperative Complications ; Prospective Studies ; Quality Improvement ; Retrospective Studies

المؤلفون: Martin M; Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Medicine Department, Universidad Complutense, Madrid, Spain; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain. Electronic address: mmartin@geicam.org., Zielinski C; Medical Oncology, Central European Cancer Center, Wiener Privatklinik Hospital, Vienna, Austria; CECOG Central European Cooperative Oncology Group, Vienna, Austria., Ruiz-Borrego M; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Universitario Virgen del Rocio, Sevilla, Spain., Carrasco E; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Turner N; Institute of Cancer Research and Royal Marsden, London, UK., Ciruelos EM; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain; Medical Oncology, HM Hospitales Madrid, Madrid, Spain; SOLTI Group on Breast Cancer Research, Barcelona, Spain., Muñoz M; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors (IDIBAPS), Barcelona, Spain., Bermejo B; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Clínico Universitario de Valencia, Valencia, Spain; Biomedical Research Institute INCLIVA, Valencia, Spain., Margeli M; GEICAM Spanish Breast Cancer Group, Madrid, Spain; B-ARGO Group, Catalan Institute of Oncology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Anton A; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Kahan Z; Department of Oncotherapy, University of Szeged, Szeged, Hungary., Csöszi T; Department of Oncology, Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelőintezet, Szolnok, Hungary., Casas MI; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Murillo L; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Clínico de Zaragoza Lozano Blesa, Zaragoza, Spain., Morales S; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Universitario Arnau de Vilanova, Lleida, Spain., Alba E; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; UGCI Medical Oncology, Hospitales Regional y Virgen de la Victoria, IBIMA, Málaga, Spain., Gal-Yam E; Department of Oncology, Institute of Oncology, Sheba Medical Center, Tel-Hashomer, Israel., Guerrero-Zotano A; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain., Calvo L; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Complejo Hospitalario A Coruña, Coruña, Spain., de la Haba-Rodriguez J; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Universitario Reina Sofia, Córdoba; Instituto Maimonides de Investigación Biomédica (IMIBIC); Universidad de Córdoba, Córdoba, Spain., Ramos M; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Centro Oncológico de Galicia, A Coruña, Coruña, Spain., Alvarez I; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Universitario Donostia-Biodonostia, San Sebastián, Spain., Garcia-Palomo A; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital de León, León, Spain., Huang Bartlett C; Pfizer, USA., Koehler M; Pfizer, USA; Repare Therapeutics, Cambridge, USA., Caballero R; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Corsaro M; Pfizer, Italy., Huang X; Pfizer, USA., Garcia-Sáenz JA; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Clínico Universitario San Carlos, Madrid, Spain., Chacón JI; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology, Hospital Virgen de la Salud, Toledo, Spain., Swift C; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden, London, UK., Thallinger C; CECOG Central European Cooperative Oncology Group, Vienna, Austria; Department of Oncology, Medical University of Vienna, Department of Oncology, Vienna, Austria., Gil-Gil M; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Institut Català d'Oncologia (ICO) & IDIBELL, L'Hospitalet, Barcelona, Spain.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Apr; Vol. 32 (4), pp. 488-499. Date of Electronic Publication: 2020 Dec 29.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Aromatase Inhibitors*/therapeutic use , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Capecitabine/therapeutic use ; EGF Family of Proteins/therapeutic use ; Humans ; Piperazines ; Pyridines ; Quality of Life ; Receptor, ErbB-2/genetics ; Receptors, Estrogen

المؤلفون: Llombart-Cussac A, Ramos M, Dalmau E, García-Saenz JA, González-Farré X, Murillo L, Calvo L, Morales S, Carañana V, González A, Fernández-Morales LA, Moreno F, Casas MI, Angulo Mdel M, Cámara MC, Garcia-Mace AI, Carrasco E, Jara-Sánchez C

المصدر: EUROPEAN JOURNAL OF CANCER
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

مصطلحات موضوعية: Antiemesis, Docetaxel-cyclophosphamide, CINV, Early breast cancer, Aprepitant

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8a292c8ce05765d5643a3db91aeb57c0
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1630

المؤلفون: Cocuron JC; BioDiscovery Institute and Department of Biological Sciences, University of North Texas, Denton, TX 76203, USA., Casas MI; NaPro Research, LLC, Washington, DC, 20018, USA., Yang F; Benson Hill Biosystems, St. Louis, MO, 63132, USA., Grotewold E; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824-6473, USA., Alonso AP; BioDiscovery Institute and Department of Biological Sciences, University of North Texas, Denton, TX 76203, USA. Electronic address: Anapaula.Alonso@unt.edu.

المصدر: Journal of chromatography. A [J Chromatogr A] 2019 Mar 29; Vol. 1589, pp. 93-104. Date of Electronic Publication: 2018 Dec 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9318488 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3778 (Electronic) Linking ISSN: 00219673 NLM ISO Abbreviation: J Chromatogr A Subsets: MEDLINE

مواضيع طبية MeSH: Cell Wall/*chemistry , Chromatography, Liquid/*methods , Phenols/*analysis , Plants/*chemistry , Tandem Mass Spectrometry/*methods, High-Throughput Screening Assays ; Limit of Detection ; Phenols/chemistry

المؤلفون: Templeton AJ; Department of Medical Oncology, St. Claraspital, Basel, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland., Rodríguez-Lescure Á; Hospital Universitario de Elche, Elche, Spain.; GEICAM (Spanish Breast Cancer Group), Madrid, Spain., Ruíz A; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain., Alba E; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Hospital Virgen de la Victoria, Málaga, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Calvo L; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Complejo Hospitalario Juan Canalejo, A Coruña, Spain., Ruíz-Borrego M; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Hospital Univ. Virgen del Rocío, Seville, Spain., Santaballa A; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Hospital Universitario La Fe, Valencia, Spain., Rodríguez CA; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain., Crespo C; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Hospital Ramón y Cajal, Madrid, Spain., Ramos M; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Centro Oncológico de Galicia, A Coruña, Spain., Gracia-Marco JM; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Hospital de Cabueñes, Gijón, Spain., Lluch A; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain., Álvarez I; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Hospital de Donostia, San Sebastián, Spain., Casas MI; GEICAM (Spanish Breast Cancer Group), Madrid, Spain., Sánchez-Aragó M; GEICAM (Spanish Breast Cancer Group), Madrid, Spain., Caballero R; GEICAM (Spanish Breast Cancer Group), Madrid, Spain., Carrasco E; GEICAM (Spanish Breast Cancer Group), Madrid, Spain., Amir E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada., Martin M; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain., Ocaña A; GEICAM (Spanish Breast Cancer Group), Madrid, Spain. albertoo@sescam.jccm.es.; Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. albertoo@sescam.jccm.es.; Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. albertoo@sescam.jccm.es.

مؤلفون مشاركون: GEICAM 9906 Study Investigators

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2018 Dec; Vol. 20 (12), pp. 1548-1556. Date of Electronic Publication: 2018 May 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphocyte Count* , Neutrophils*, Biomarkers, Tumor/*immunology , Breast Neoplasms/*immunology, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor/blood ; Breast Neoplasms/drug therapy ; Breast Neoplasms/mortality ; Chemotherapy, Adjuvant ; Clinical Trials, Phase III as Topic ; Disease-Free Survival ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Retrospective Studies

المؤلفون: Martín M; Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain mmartin@geicam.org.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain., Chacón JI; Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain., Antón A; Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Plazaola A; Oncology Department, Onkologikoa, San Sebastián, Spain., García-Martínez E; Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain., Seguí MA; Oncology Department, Corporación Sanitaria Parc Taulí, Barcelona, Spain., Sánchez-Rovira P; Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain., Palacios J; Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain., Calvo L; Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain., Esteban C; Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain., Espinosa E; Oncology Department, Hospital Universitario la Paz, Madrid, Spain., Barnadas A; Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Institut de Recerca IIB Sant Pau, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain., Batista N; Oncology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain., Guerrero A; Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain., Muñoz M; Oncology Department, Hospital Clinic i Provincial, Barcelona, Spain., Romio E; Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Rodríguez-Martín C; GEICAM headquarters, Madrid, Spain., Caballero R; GEICAM headquarters, Madrid, Spain., Casas MI; GEICAM headquarters, Madrid, Spain., Rojo F; Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain., Carrasco E; GEICAM headquarters, Madrid, Spain., Antolín S; Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain.

المصدر: The oncologist [Oncologist] 2017 Nov; Vol. 22 (11), pp. 1301-1308. Date of Electronic Publication: 2017 Jul 12.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Albumin-Bound Paclitaxel/*administration & dosage , Breast Neoplasms/*drug therapy , Drug-Related Side Effects and Adverse Reactions/*epidemiology , Nanoparticles/*administration & dosage, Adult ; Aged ; Albumin-Bound Paclitaxel/chemistry ; Breast Neoplasms/epidemiology ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Drug-Related Side Effects and Adverse Reactions/pathology ; Estrogen Receptor alpha/genetics ; Female ; Humans ; Middle Aged ; Nanoparticles/chemistry ; Receptor, ErbB-2/genetics

المؤلفون: Casas MI; Molecular Cellular and Developmental Biology Graduate Program, The Ohio State University, 1060 Carmack Road, Columbus, OH 43210, USA; Center for Applied Plant Sciences (CAPS), The Ohio State University, 1060 Carmack Road, Columbus, OH 43210, USA; Department of Molecular Genetics, The Ohio State University, 1060 Carmack Road, Columbus, OH 43210, USA., Vaughan MJ; Center for Applied Plant Sciences (CAPS), The Ohio State University, 1060 Carmack Road, Columbus, OH 43210, USA; Department of Plant Pathology, The Ohio State University-OARDC, 1680 Madison Ave.,Wooster, OH, 44691, USA., Bonello P; Center for Applied Plant Sciences (CAPS), The Ohio State University, 1060 Carmack Road, Columbus, OH 43210, USA; Department of Plant Pathology, The Ohio State University, 2021 Coffey Road, Columbus, OH 43210, USA., McSpadden Gardener B; Center for Applied Plant Sciences (CAPS), The Ohio State University, 1060 Carmack Road, Columbus, OH 43210, USA; Department of Plant Pathology, The Ohio State University, 2021 Coffey Road, Columbus, OH 43210, USA., Grotewold E; Center for Applied Plant Sciences (CAPS), The Ohio State University, 1060 Carmack Road, Columbus, OH 43210, USA; Department of Molecular Genetics, The Ohio State University, 1060 Carmack Road, Columbus, OH 43210, USA., Alonso AP; Center for Applied Plant Sciences (CAPS), The Ohio State University, 1060 Carmack Road, Columbus, OH 43210, USA; Department of Molecular Genetics, The Ohio State University, 1060 Carmack Road, Columbus, OH 43210, USA. Electronic address: alonso.19@osu.edu.

المصدر: Food research international (Ottawa, Ont.) [Food Res Int] 2017 May; Vol. 95, pp. 59-67. Date of Electronic Publication: 2017 Feb 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Published on behalf of the Canadian Institute of Food Science and Technology by Elsevier Applied Science Country of Publication: Canada NLM ID: 9210143 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7145 (Electronic) Linking ISSN: 09639969 NLM ISO Abbreviation: Food Res Int Subsets: MEDLINE

مواضيع طبية MeSH: Coffea/*chemistry , Coffee/*chemistry, Amino Acids/analysis ; Antioxidants/analysis ; Chemical Phenomena ; Food Handling ; Hot Temperature ; Seeds/chemistry ; Volatile Organic Compounds/analysis